Pure Global

ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) - ANVISA Registration 80020690418

Access comprehensive regulatory information for ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80020690418 and manufactured by manufacturer not specified. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until Sep 13, 2031.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including QUIBASA QUÍMICA BÁSICA LTDA, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80020690418
2 Related Devices
Registration Details
ANVISA Registration Number: 80020690418
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Related Devices (2)

Registration Details

80020690418

25351490255202136

03188198000177

Company Information

Dates and Status

Sep 13, 2021

13/09/2031

09/18/2025 19:00:01

Registration Details

80020690418

25351490255202136

03188198000177

Company Information

BIO-RAD
France
PT: FRANÇA

Dates and Status

Sep 13, 2021

13/09/2031

09/18/2025 19:00:01